STAT

JULY 19, 2024

On Thursday, a widespread outage to Microsoft systems took down computers in health systems around the globe, leading many to cancel non-urgent medical appointments and surgeries as they encouraged patients to make plans for disrupted travel and delays in care. “A major worldwide software outage has affected many of our systems at Mass General Brigham,” the hospital system shared in a statement on Friday.

Scheduling Appointments 362

Scheduling Appointments Hospitals 362

PharmaVoice

JULY 19, 2024

The pharma company is tackling the “stiff person syndrome” that afflicts Celine Dion in a phase 2 trial for its lead CAR-T candidate.

173

173

STAT

JULY 19, 2024

The first time I saw Maya (not her real name) huddled under blankets in a hospital bed in 2013, she had been to dozens of inpatient detox programs and residential treatment centers since she had begun using heroin two decades earlier. After every release, she returned to heroin use, usually within days. Why didn’t treatment “stick”?

Inpatient 353

Inpatient Hospitals 353

PharmaVoice

JULY 19, 2024

Merdad Parsey joined Gilead as its chief medical officer in 2019 and has helped lead the company’s expansion into oncology, with mixed success.

147

147

Speaker: Joe Sharpe and James Carlson

In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.

STAT

JULY 19, 2024

WastewaterSCAN, one of the United States’ largest private entities that provide real-time data on pathogens in wastewater, has stopped collecting data from 43 facilities due to “resource constraints,” according to emails the company sent to staff overseeing these sites. The group — based at Stanford University, in partnership with Emory University — had been collecting samples from 194 sites in 41 states and the District of Columbia, a swath including 39 millio

352

352

The Pharmacist

JULY 19, 2024

The community pharmacy network must be properly funded and included in planning to improve any future response to a pandemic, the National Pharmacy Association (NPA) has said. This comes as the first report of the Covid-19 inquiry found that the UK ‘lacked resilience’ going into the pandemic, with health services under pressure and high levels […] The post Pharmacy 'vital' to pandemic response planning appeared first on The Pharmacist.

Community Pharmacies 110

Community Pharmacies Vaccines 110

The Pharmacist

JULY 19, 2024

Pharmacies may need to make emergency medicine supplies under Pharmacy First amid IT issues affecting prescription systems, Community Pharmacy England (CPE) has suggested. Alastair Buxton, CPE director of NHS services, told The Pharmacist today that patients unable to contact their general practice for an urgent supply of a prescription medicine could seek assistance from NHS 111.

Community Pharmacies 108

Community Pharmacies 108

STAT

JULY 19, 2024

At a contentious advisory committee meeting in June, the Food and Drug Administration announced it was investigating allegations of data suppression and misconduct in clinical trials of MDMA-assisted therapy. The agency was “quite concerned” by claims included in a report from the Institute for Clinical and Economic Review think tank, agency psychiatry director Tiffany Farchione told the ad comm, and planned to complete its investigation before deciding whether to approve Lykos The

329

329

Pharmafile

JULY 19, 2024

GSK has announced that the European Medicines Agency (EMA) has accepted the marketing authorisation application (MAA) for Blenrep (belantamab mafodotin) in combination with bortezombin plus dexamethasone (BorDex) or pomalidomide plus dexamethasone (PomDex) as a treatment for relapsed or refractory (R/R) multiple myeloma (MM). The post GSK’s application for Blenrep for MM treatment accepted for EMA review appeared first on Pharmafile.

105

105

STAT

JULY 19, 2024

By dismissing a case that would have determined whether emergency abortion care is encompassed under the Emergency Medical Treatment and Labor Act (EMTALA), along with other protected emergency care services, the Supreme Court of the United States has opened the door for states to deny women stabilizing and often lifesaving medical procedures. For nearly 40 years, EMTALA has protected access to emergency services regardless of a person’s ability to pay, citizenship, or legal status.

Hospitals 301

Hospitals 301

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

JULY 19, 2024

FDA will create a rare disease hub to speed the development of new treatments and build connections between developers and the rare disease community

115

115

STAT

JULY 19, 2024

Hellloooooo. Today, we discuss the FDA’s lack of engagement with critics of MDMA for PTSD therapy. We also highlight a massive veterans study on genomics, and how it illustrates the importance of studying diverse populations. And there’s more. FDA silent on claims of misconduct in MDMA trials At last month’s advisory committee meeting about Lykos Therapeutics’ MDMA-assisted therapy, the FDA said that it would investigate allegations of data suppression and misconduct

Drug Pricing 252

Drug Pricing Drug Development 252

Pharmaceutical Commerce

JULY 19, 2024

FDA to review one-year results for Susvimo showing non-inferior visual acuity gains in diabetic macular edema and in the Diabetic Retinopathy Severity Scale for Diabetic Retinopathy.

Diabetes 104

Diabetes 104

STAT

JULY 19, 2024

For many New Yorkers, Dave Chokshi was the face of New York City’s public health response to Covid-19. He often appeared on public service announcements in a white lab coat emblazoned with“N-Y-C” in big, bold letters, urging urbanites to mask up , get tested , and get vaccinated. Appointed as New York City’s 43rd health commissioner in August 2020, Chokshi was thrust into the city’s battle against the coronavirus just months after it was deemed an epicenter of

Vaccines 251

Vaccines Hospitals 251

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

JULY 19, 2024

Explore the emerging uses and future directions of chimeric antigen receptor T-cell therapy targeting mRNA, anti-EGFRvIII, and anti-NY-ESO-1 antigens in cancer treatments.

102

102

STAT

JULY 19, 2024

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, so far, includes fraternizing with assorted family types, promenading with the official mascots, and catching up on our reading. We also hope to hold another listening party, where the rotation will likely include this , this , this and this.

Diabetes 241

Diabetes 241

The Pharmacist

JULY 19, 2024

Major IT outages have disrupted prescription access and medicines delivery today, the National Pharmacy Association (NPA) has confirmed. IT issues affecting the 'majority' of GP practices are blocking access to electronic prescriptions and patient records. And NHS England (NHSE) has suggested that paper prescriptions can be used 'to manage the disruption'.

97

97

STAT

JULY 19, 2024

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

193

193

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharma Times

JULY 19, 2024

LT-HSCs replenish blood cells after treatment for blood cancers, such as leukaemia

132

132

Express Pharma

JULY 19, 2024

CDIOs are more prevalent in industrial (40 per cent) followed by Pharma (36 per cent), and then other sectors In the dynamic landscape of modern business, the role of Chief Information Officers (CIOs) has undergone a profound evolution, transforming into what is now widely recognised as the Chief Digital and Information Officer (CDIO). WalkWater Talent Advisors has released a comprehensive talent report on the CDIO role.

94

94

pharmaphorum

JULY 19, 2024

While the pace of biotech private rounds seems to have slowed a little of late, this week saw four big financings for Cardurion Pharma, Scorpion Therapeutics, CatalYm, and NGM Bio.Burlington, Massachusetts-based Cardurion led the quartet with a $260 million Series B for its heart-focused drug pipeline, which features two candidates in phase 2 testing – PDE9 inhibitor CRD-750 for heart failure and CaMKII inhibitor CRD-4730 for rare genetic disease catecholaminergic polymorphic ventricular tachyca

93

93

Outsourcing Pharma

JULY 19, 2024

Avista, a New York-based private equity firm focused on healthcare, and Hamilton Lane, a global private markets investment management firm, have announced that funds managed by Hamilton Lane have acquired a significant equity interest in Cosette Pharmaceuticals from Avista and its co-investors.

89

89

pharmaphorum

JULY 19, 2024

Explore the emerging era of digital health and pharmaceuticals with PDURS, featuring insights from industry experts Marty Culjat of EVERSANA and Edward Cox of Pfizer.

94

94

Pharma Times

JULY 19, 2024

Chronic pelvic pain is a disabling condition that affects around one in four women worldwide

115

115

pharmaphorum

JULY 19, 2024

Less than two years after pulling multiple myeloma therapy Blenrep off most markets around the world, GSK has filed for approval of the drug in the EU once again, hoping to restore its blockbuster credentials.The remarkable renaissance for the BCMA-directed antibody-drug conjugate is supported by a pair of phase 3 trials that could not only support its return but also make it an option for a much larger patient population than before.

91

91

Outsourcing Pharma

JULY 19, 2024

Phathom Pharmaceuticals, Inc.dedicated to developing and commercializing treatments for gastrointestinal (GI) diseases, announced today that the US Food and Drug Administration (FDA) has approved Voquenza (vonoprazan) 10mg tablets for the relief of heartburn associated with non-erosive gastroesophageal reflux disease (non-erosive GERD) in adults.

82

82

pharmaphorum

JULY 19, 2024

NICE backs NHS use of Accord's Orgovyx, the first therapy for advanced hormone-sensitive prostate cancer that can be taken at home

102

102

Pharma Times

JULY 19, 2024

Accreditation recognises 'continued professional development' opportunities

Communication 110

Communication 110

BioPharma Dive

JULY 19, 2024

Federal filings showed no companies other than Lilly made an offer to buy Morphic, while Novartis executives said they’re still waiting for more data on pelabresib.

76

76

World Pharma News

JULY 19, 2024

Relapsed/refractory acute myeloid leukemia (AML), a so-called blood cancer, has an extremely poor prognosis because of resistance to anti-cancer drugs and frailty of the patient’s organ functions. A type of anti-tumor immunotherapy called allogeneic hematopoietic cell transplantation, which can exert anti-cancer effect accompanied by severe toxicity, is often performed for patients who are hard to treat with chemotherapy, but relapse still remains.

Chemotherapy 67

Chemotherapy 67

Pharmaceutical Business Review

JULY 19, 2024

This designation aims to expedite the development and review of the therapy for paediatric patients with early-stage type 1 diabetes carrying the HLA DR3-DQ2 genotype. The status aids in the development and speeding up of the review processes of medicines for treating various serious conditions and filling an unmet medical need. Diamyd, which targets the preservation of insulin production, is now recognised for its potential to address an unmet medical need in both the early and later stages of

Diabetes 59

Diabetes 59

Pharmafile

JULY 19, 2024

Brainomix has announced that it has entered into a strategic partnership with Boehringer Ingelheim for a collaborative programme surrounding the care of patients with fibrosing lung disease in the US. The post Brainomix and Boehringer Ingelheim enter strategic partnership appeared first on Pharmafile.

59

59

European Pharmaceutical Review

JULY 19, 2024

This report delves into the latest advances and developments impacting pharmaceutical drug formulators today. Inside, articles explore current vast expansion of the formulation including patient centricity, excipients, safety, quality and regulatory considerations. Stay up to date with the latest developments in drug formulation including articles on: The trends and challenges for OSD and patient centric formulations Cell and gene therapy formulation including the prominent issues and opportunit

59

59